Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Supaglutide

A Study of Supaglutide in Chinese Type 2 Diabetes Patients

Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2 · Completed · Enrollment 40

NCT04314622

ArmPopulationDoseWeeksEstimandWeight change
Supaglutide (Part A)T2D onlyn/rn/rn/rn/r
Placebo(Part A)T2D onlyn/rn/rn/rn/r
Supaglutide (Part B)T2D onlyn/rn/rn/rn/r
Placebo (Part B)T2D onlyn/rn/rn/rn/r